Limited CRNA Scope Changes, Disclosure of Drug Pricing Being Considered

[March 7, 2019]

SB 61 alters the prescribing authority to allow CRNAs to “select, order, and administer drugs other than anesthesia” in the immediate post-operative period. 

Also being considered is HB 63, dealing with disclosure of drug prices. The bill, which is on the Ohio House Health Committee agenda for March 12, requires a pharmacist to disclose to patients if their prescriptions would cost less if purchased without insurance coverage. Patient cannot be charged this higher price and should not be charged more than: 1) the cost of the prescription without insurance coverage, or 2) the reimbursement paid to the pharmacy for the prescription.

Also being heard in committee next week is HB 102, regarding Medicaid coverage of chiropractic services.  The bill would require Medicaid to cover chiropractic services for recipients, offering no less than 20 visits to any participating licensed chiropractor acting within their scope of practice. Medicaid would not be able to impose a prior authorization or referral requirements for these services.

Printer-Friendly Version